Osaic Holdings’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Osaic Holdings’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,518	Closed	-$50K	–	7747
2022 Q3	$50K	Hold	2,518	–	–	﹤0.01%	4909
2022 Q2	$18K	Hold	2,518	–	–	﹤0.01%	5704
2022 Q1	$33K	Buy	2,518 +2,504	+17,886%	+$26.7K	﹤0.01%	5392
2021 Q4	$0	Buy	+14	New	+$242	﹤0.01%	7736
2021 Q3	–	Sell	-965	Closed	-$24K	–	7442
2021 Q2	$24K	Buy	965 +300	+45%	+$8.06K	﹤0.01%	5557
2021 Q1	$19K	Hold	665	–	–	﹤0.01%	5540
2020 Q4	$23K	Hold	665	–	–	﹤0.01%	5084
2020 Q3	$33K	Buy	+665	New	+$26.9K	﹤0.01%	4608

Osaic Holdings's FMTX Position: Q4 2022 in Review

Osaic Holdings sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 2,518 shares — an estimated $50K sold.

Osaic Holdings first reported a position in FMTX in Q3 2020 and held it in 8 quarters. The position peaked at $50K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Osaic Holdings reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Osaic Holdings sold 2,518 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $50K.
Osaic Holdings first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
Osaic Holdings's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $50K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.